Regulation of R-loop Formation and Genome Stability by ADAR1
Regulation of R-loop Formation and Genome Stability by ADAR1
批准号:
10245039
负责人:
KAZUKO NISHIKURA
金额:
$47.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-07-01 至 2023-08-31
关键词:
ADAR1AdenosineAffectAffinity ChromatographyAmyotrophic Lateral SclerosisApoptosisApoptoticApraxiasAtaxiaAutoimmune DiseasesBeesBiologicalBiological ProcessCellsCellular StressCentromereChimeric ProteinsChromosomesComplexDNADNA DamageDRADA2b proteinDevelopmentDiseaseDissociationDouble-Stranded RNAElementsEmbryoEvolutionFamily memberFragile X SyndromeFrontotemporal DementiaGene FamilyGenesGenetic TranscriptionGenome StabilityGenomic InstabilityGoalsGrantHela CellsHuman GenomeHybridsIn VitroInflammatory ResponseInosineInterferonsKnockout MiceKnowledgeLaboratoriesLocationMaintenanceMediatingMicroRNAsMitogen-Activated Protein KinasesMitoticMolecularMonoclonal AntibodiesMutationNatural ImmunityNucleic AcidsOligonucleotidesPathogenesisPatientsPlayProductionProteinsRNARNA DegradationRNA EditingRNA InterferenceRNA helicase ARNA-specific adenosine deaminase 3Recombinant ProteinsRegulationRepetitive SequenceResearchResolutionRetrotransposonRibonucleasesRoleShort Interspersed Nucleotide ElementsStructureSubgroupSystemTERF1 geneTestingTimeTranscriptadenosine deaminasebiological adaptation to stressdesignembryo cellexperimental studyhuman diseasein vivoknock-downmRNA Decaymembermutantpre-miRNApri-miRNApseudotoxoplasmosis syndromereconstitutionreplication stressresponseribonuclease H1telomerevertebrate genome
中文摘要
项目摘要
阿达尔(作用于RNA的腺苷脱氨酶)将腺苷残基转化为肌苷(A-to-IRNA
编辑)在双链RNA中。在过去27年的拨款之初,我们确定了
ADAR 1是阿达尔基因家族的第一个成员。这反过来又导致了ADAR 2和ADAR 3的鉴定。
从那时起,我们为A-to-I RNA编辑领域的发展做出了重大贡献,特别是通过
重点是了解ADAR 1的生物学功能。ADAR 1似乎有多种功能,
编辑依赖性和其他编辑无关性,在选择基因的蛋白质编码中,
逆转录转座子衍生的重复元件,先天免疫的抑制,RNA干扰的调节,以及
应激反应即便如此,目前尚不清楚这些已经描述的ADAR 1功能是否是
ADAR 1基因在脊椎动物基因组进化过程中得以保留的原因。
新生RNA通常在转录后从其模板DNA链上解离,但偶尔也会从模板DNA链上解离。
新转录的RNA形成稳定的RNA:DNA杂交体,其结果之一是留下有义DNA
以单链形式存在。这种结构被称为R环,并导致转录失败和转录不稳定。
基因组,导致DNA损伤,突变和复制压力。R环积累导致人类
Aicardi-Goutières综合征(AGS)是一种由炎症引起的严重自身免疫性疾病,
对核酸的反应。有趣的是,在AGS患者的亚组(AGS 6)中,疾病是以下因素的结果:
ADAR 1突变实验上,我们已经获得了初步的结果表明,ADAR 1
敲低导致R环的显著积累和有丝分裂灾难。
在下一个资助期内,我们将探索ADAR 1的R环调节功能及其在细胞内的表达。
与维持人类基因组稳定性的机制相关。我们将首先调查R-
使用重组蛋白和重组的R环结构进行体外环解离机制
合成RNA/DNA寡核苷酸。我们将研究如何影响R环解离的效率
通过ADAR 1介导的A到I RNA编辑。我们将在全球范围内确定R环的精确位置
通过分离的R环的RNA和DNA链的DRIP-seq由ADAR 1特异性调节。我们
将可视化特定的染色体区域,如着丝粒和端粒,其中R-
环可以通过ADAR 1使用与区域特异性标记融合的荧光蛋白进行特异性调节,
如CENPA和TRF 1。最后,我们将检验我们的假设,即积累的R环是致病核酸,
在ADAR 1缺失小鼠胚胎中检测到的异常IFN产生和炎症反应的酸,
AGS 6患者。从ADAR 1缺失小鼠胚胎和携带ADAR 1的HeLa细胞中分离的R环
AGS 6的突变将通过DRIP-seq进行研究。总之,这些实验将揭示
ADAR 1最重要的体内功能,即维持基因组稳定性。
英文摘要
PROJECT SUMMARY
ADAR (adenosine deaminase acting on RNA) converts adenosine residues to inosine (A-to-I RNA
editing) in double-stranded RNA. At the very beginning of the previous 27 years of this grant, we identified
ADAR1, the first member of the ADAR gene family. This in turn led to the identification of ADAR2 and ADAR3.
Since then we have made major contributions to development of the A-to-I RNA editing field, in particular by
focusing on understanding the biological functions of ADAR1. ADAR1 seems to have multiple functions, some
editing-dependent and the others editing-independent, in protein-recoding of select genes, editing of
retrotransposon derived repeat elements, suppression of innate immunity, regulation of RNA interference, and
stress response. Even so, it is not yet clear whether these already described ADAR1 functions are the
reasons why the ADAR1 gene has been retained over the course of evolution of the vertebrate genome.
Nascent RNA usually dissociates from its template DNA strand after transcription, but occasionally the
newly transcribed RNA forms a stable RNA:DNA hybrid, one consequence of which is leaving the sense DNA
in a single-stranded form. This structure is called an R-loop, and causes abortive transcription and instability of
the genome, resulting in DNA damage, mutations, and replication stress. R-loop accumulation leads to human
diseases such as Aicardi-Goutières syndrome (AGS), a severe autoimmune disease caused by inflammatory
responses to nucleic acids. Interestingly, in a subgroup of AGS patients (AGS6), the disease is a result of
mutations in ADAR1. Experimentally, we have obtained preliminary results suggesting that ADAR1
knockdown results in significant accumulation of R-loops and mitotic catastrophe.
During the next grant support period, we will explore the R-loop regulatory function of ADAR1 and its
relevance to the mechanisms that maintain the stability of the human genome. We will first investigate the R-
loop dissociation mechanism in vitro using recombinant proteins and a reconstituted R-loop structure made
with synthetic RNA/DNA oligonucleotides. We will examine how the efficiency of R-loop dissociation is affected
by A-to-I RNA editing mediated by ADAR1. We will determine globally the precise locations of R-loops
specifically regulated by ADAR1 by DRIP-seq of both the RNA and the DNA strands of isolated R-loops. We
will visualize particular chromosome regions, such as centromeres and telomeres, where persistence of R-
loops may be specifically regulated by ADAR1 using fluorescent proteins fused to region specific markers such
as CENPA and TRF1. Finally, we will test our hypothesis that accumulated R-loops are the causative nucleic
acids for aberrant IFN production and inflammatory responses detected in ADAR1 null mouse embryos and
AGS6 patients. R-loops isolated from ADAR1 null mouse embryos and HeLa cells carrying the ADAR1
mutations of AGS6 will be investigated by DRIP-seq. Together, these experiments will reveal the evolutionarily
most important in vivo function of ADAR1, namely maintenance of genome stability.
期刊论文(47)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.cell.2013.03.024
发表时间:
2013-04-25
期刊:
Cell
影响因子:
64.5
作者:
[Ota H, Sakurai M, Gupta R, Valente L, Wulff BE, Ariyoshi K, Iizasa H, Davuluri RV, Nishikura K]
通讯作者:
Nishikura K
DOI:
10.1002/j.1460-2075.1996.tb00331.x
发表时间:
1996-01-02
期刊:
EMBO JOURNAL
影响因子:
11.4
作者:
[Dabiri, GA, Lai, F, Nishikura, K]
通讯作者:
Nishikura, K
DOI:
10.1038/s41467-021-21921-x
发表时间:
2021-03-12
期刊:
Nature communications
影响因子:
16.6
作者:
[Shiromoto Y, Sakurai M, Minakuchi M, Ariyoshi K, Nishikura K]
通讯作者:
Nishikura K
DOI:
10.1006/scel.1993.1034
发表时间:
1993-08
期刊:
Seminars in cell biology
影响因子:
--
作者:
[Unkyu Kim;K. Nishikura]
通讯作者:
Unkyu Kim;K. Nishikura
The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis.
GABRA3 的 mRNA 编辑形式抑制 GABRA3 介导的 Akt 激活和乳腺癌转移
DOI:
10.1038/ncomms10715
发表时间:
2016-02-12
期刊:
Nature communications
影响因子:
16.6
作者:
[Gumireddy K, Li A, Kossenkov AV, Sakurai M, Yan J, Li Y, Xu H, Wang J, Zhang PJ, Zhang L, Showe LC, Nishikura K, Huang Q]
通讯作者:
Huang Q
共 25 条
Stress Response Functions of ADAR1 Regulated by MAP Kinases
-
批准号:10330572
-
项目类别:
-
资助金额:$37.51万
-
财政年份:2019
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Stress Response Functions of ADAR1 Regulated by MAP Kinases
-
批准号:10093094
-
项目类别:
-
资助金额:$37.51万
-
财政年份:2019
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Control of Breast Cancer Metastasis by Epstein-Barr Virus microRNA
-
批准号:8625434
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2014
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Control of Breast Cancer Metastasis by Epstein-Barr Virus microRNA
-
批准号:9187428
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2014
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Control of Cardiogenesis by microRNA Editing
-
批准号:7934485
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Control of Cardiogenesis by microRNA Editing
-
批准号:7810127
-
项目类别:
-
资助金额:$49.02万
-
财政年份:2009
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Characterization of TRBP-containing complexes
-
批准号:7146839
-
项目类别:
-
资助金额:$28.08万
-
财政年份:2006
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Functions of ADARI RNA Editase in Erythropoiesis
-
批准号:6746917
-
项目类别:
-
资助金额:$45.63万
-
财政年份:2002
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Functions of ADARI RNA Editase in Erythropoiesis
-
批准号:6465404
-
项目类别:
-
资助金额:$35.96万
-
财政年份:2002
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Functions of ADARI RNA Editase in Erythropoiesis
-
批准号:6833858
-
项目类别:
-
资助金额:$4.45万
-
财政年份:2002
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Functions of ADARI RNA Editase in Erythropoiesis
-
批准号:6912766
-
项目类别:
-
资助金额:$46.06万
-
财政年份:2002
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Functions of ADARI RNA Editase in Erythropoiesis
-
批准号:6623407
-
项目类别:
-
资助金额:$36.36万
-
财政年份:2002
-
负责人:KAZUKO NISHIKURA
-
依托单位:
EFFECTS OF DSRNA ADENOSINE DEAMINASE (DRADA) ON ANTISENSE RNA STRATEGY
-
批准号:6477406
-
项目类别:
-
资助金额:$16.54万
-
财政年份:2001
-
负责人:KAZUKO NISHIKURA
-
依托单位:
EFFECTS OF DSRNA ADENOSINE DEAMINASE (DRADA) ON ANTISENSE RNA STRATEGY
-
批准号:6336431
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2000
-
负责人:KAZUKO NISHIKURA
-
依托单位:
EFFECTS OF DSRNA ADENOSINE DEAMINASE (DRADA) ON ANTISENSE RNA STRATEGY
-
批准号:6344744
-
项目类别:
-
资助金额:$16.54万
-
财政年份:2000
-
负责人:KAZUKO NISHIKURA
-
依托单位:
EFFECTS OF DSRNA ADENOSINE DEAMINASE (DRADA) ON ANTISENSE RNA STRATEGY
-
批准号:6217497
-
项目类别:
-
资助金额:$21.6万
-
财政年份:1999
-
负责人:KAZUKO NISHIKURA
-
依托单位:
EFFECTS OF DSRNA ADENOSINE DEAMINASE (DRADA) ON ANTISENSE RNA STRATEGY
-
批准号:6103321
-
项目类别:
-
资助金额:$21.6万
-
财政年份:1999
-
负责人:KAZUKO NISHIKURA
-
依托单位:
EFFECTS OF DSRNA ADENOSINE DEAMINASE (DRADA) ON ANTISENSE RNA STRATEGY
-
批准号:6269811
-
项目类别:
-
资助金额:$21.71万
-
财政年份:1998
-
负责人:KAZUKO NISHIKURA
-
依托单位:
EFFECTS OF DSRNA ADENOSINE DEAMINASE (DRADA) ON ANTISENSE RNA STRATEGY
-
批准号:6296149
-
项目类别:
-
资助金额:$21.71万
-
财政年份:1998
-
负责人:KAZUKO NISHIKURA
-
依托单位:
EFFECTS OF DSRNA ADENOSINE DEAMINASE (DRADA) ON ANTISENSE RNA STRATEGY
-
批准号:6237788
-
项目类别:
-
资助金额:$21.67万
-
财政年份:1997
-
负责人:KAZUKO NISHIKURA
-
依托单位:
国内基金
海外基金
基于ADK/Adenosine调控DNA甲基化探讨“利湿化瘀通络”法对2型糖尿病肾病足细胞裂孔膜损伤的干预机制研究
-
批准号:82074359
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:安晓飞
-
依托单位:
细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
-
批准号:81570244
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:丁兆平
-
依托单位:
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
-
批准号:81171113
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:黄文
-
依托单位: